Drug Abuse Science Gets Partial Public Peep Show
Published Date: 3/25/2025
Notice
Summary
The National Institute on Drug Abuse is holding a virtual meeting on May 13, 2025, to review grant applications and discuss important drug research topics. This meeting affects researchers and organizations seeking funding, with some parts open to the public and others private to protect sensitive info. No direct money changes are announced, but grant decisions could impact future funding.
Analyzed Economic Effects
5 provisions identified: 4 benefits, 0 costs, 1 mixed.
NIDA Will Review Grant Applications
On May 13, 2025, the National Advisory Council on Drug Abuse will meet virtually to review and evaluate grant applications (closed session 11:00 a.m. to 12:15 p.m.). This meeting directly concerns researchers and organizations that have submitted grant applications to the Institute.
Open Session Videocast for Public Viewing
The Council's open session on May 13, 2025, from 1:30 p.m. to 5:00 p.m. will be videocast and can be accessed from the NIH Videocasting and Podcasting website. Anyone may view the presentations and business of the Council via that videocast.
Portion Closed to Protect Confidential Information
A portion of the May 13, 2025 meeting (11:00 a.m. to 12:15 p.m.) will be closed to the public under 5 U.S.C. 552b(c)(4) and (c)(6) to protect confidential trade secrets, commercial property, patentable material, and personal information tied to grant applications. That closed review applies to applicants whose materials could disclose confidential or personally sensitive information.
Anyone May File Written Comments
Any interested person may file written comments for the committee by emailing Dr. Gillian Acca; comments should include name, address, telephone number, and, when applicable, business or professional affiliation. The notice provides a clear, open channel for public input to the Council.
Accessibility Accommodations Available by Request
Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Dr. Gillian Acca by email five days before the May 13, 2025 meeting. The Institute provides a process to request accommodations for the videocast.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
2026-19804, Submission for OMB Review; 30-Day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
The NIH is asking for approval to keep collecting info from citizen science and crowdsourcing projects, making it easier to gather public input on health research. This affects anyone involved in these projects and invites comments by October 28, 2026. No new costs or big changes, just a smooth way to keep the data flowing for better science!
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
2026-19706, Draft NIH Policy on Sharing Summary Level Study Results With Clinical Research Participants
The NIH wants to make it easier for people who join clinical studies to get simple summaries of the study results. This new policy aims to boost trust and teamwork between researchers and participants, helping science move faster and better. They’re asking for your thoughts by October 26, 2026, so get ready to share your ideas!
2026-19431, Government-Owned Inventions; Availability for Licensing
The government is offering a new invention for licensing that makes stem cell transplants safer and less harsh, especially for leukemia patients and older folks. This tech uses a special protein to prepare patients for transplants without the tough side effects of chemo and radiation. Companies can start licensing this preclinical innovation now to help bring better treatments to market faster.
Previous / Next Documents
Previous: 2025-04980, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a private virtual meeting on May 1, 2025, to review grant applications. This meeting affects researchers seeking funding for diabetes, digestive, and kidney disease studies. No public access or money changes are involved, but the review helps decide who gets research support.
Next: 2025-04982, Certain Active Matrix Organic Light-Emitting Diode Display Panels and Modules for Mobile Devices, and Components Thereof; Notice of the Commission's Final Determination Finding No Violation of Section 337; Termination of the Investigation
The U.S. International Trade Commission has decided that certain OLED display panels and parts for mobile devices don’t violate any patent rules. This means the investigation started by Samsung Display is officially over, and no penalties or import bans will happen. Companies making or selling these parts in the U.S. can keep doing business without worry.